Most exercise and aging studies can't answer a basic question: is muscle deterioration from aging itself, or just from decades of moving less? A new Nature Aging study solved this by recruiting older adults who moved as much as people in their twenties. The researchers from Amsterdam UMC and Maastricht University recruited four distinct groups: young adults in their twenties, older adults whose daily step counts and high-intensity activity matched the young group, older adults who had trained consistently for years (three structured hour-long sessions per week for over a year), and older adults with early physical impairment. They took muscle biopsies before and after a one-hour cycling session, then measured over 24,000 gene transcripts, 135 metabolites, and 1,383 lipid species. By matching activity levels between young and older groups, any molecular differences couldn't be blamed on the older adults simply moving less. This isolated aging from inactivity for the first time at this molecular depth. Key findings: • The defining molecular signature of muscle aging is an energy crisis. Comparing young adults to activity-matched older adults, 1,106 genes were downregulated with age. These genes build the mitochondrial machinery that produces cellular energy: ATP synthase, cytochrome c oxidase, and NADH dehydrogenase subunits. Mitochondria are the power plants of cells, converting nutrients into ATP, the energy currency cells use to function. When these genes decline, cells lose their ability to generate energy efficiently. • NAD+ levels declined and triglycerides accumulated inside aging muscle. NAD+ is a molecule required for energy production and cellular repair. Lower NAD+ means less capacity to convert fuel into usable energy. Triglycerides are stored fats, their accumulation inside muscle indicates unburned fuel piling up as the tissue loses its ability to process it. • More than half the molecular signature of muscle aging was absent in trained older adults. Specifically, 57.1% of age-related gene downregulation and 55.9% of upregulation were missing in the trained group. Their muscle resembled young adults far more than their chronological age would predict. • The changes training preserved were specifically the energy metabolism ones. Genes like NDUFS1 and COX5A, which were depleted in normally active and impaired older adults, sat at youthful levels in the trained group across all five mitochondrial respiratory complexes. The single most prominent feature of muscle aging turned out to be the single most preventable. • Being generally active was not enough. Structured training was the difference. The normally active older adults walked as much as young adults, and their energy metabolism genes declined anyway. What preserved the youthful molecular profile was structured, sustained training. Filling a step counter and being genuinely trained are not equivalent at the molecular level. • Roughly half of muscle aging persisted regardless of training. Changes in genes controlling synaptic transmission (how nerves communicate with muscle) and WNT signaling (a pathway regulating tissue maintenance and stem cell function) appeared in all older adults, trained or not. This unavoidable half is where drugs will have to work. • The fittest muscle mounted the largest inflammatory response to exercise. All groups activated stress and immune genes after exercise, including IL6, IL1B, and TNF. But the magnitude scaled with fitness. Trained older adults most closely resembled young adults in their response, followed by normally active, with impaired older adults showing the most blunted response. The stress response to exercise appears to be the mechanism of adaptation, not damage to be minimized. This raises a concern about anti-inflammatory longevity strategies. If the inflammatory stress response is how exercise produces its benefits, chronically suppressing inflammation may blunt the adaptation that exercise depends on. It doesn't mean inflammation is beneficial in general, but the timing and context matter. A separate discovery: the proteasome appears to regulate NAD+. The proteasome is the cellular machinery that breaks down damaged proteins. When researchers inhibited it, NAD+ levels rose in both muscle and liver cells to a degree comparable to NAD+ precursor supplements. This opens a new route to understanding NAD+ decline that operates through protein turnover rather than just supplying more raw material. The study draws a clear line between what lifestyle can address and what will require therapeutics. The energy metabolism decline, mitochondrial deterioration, and NAD+ depletion that define muscle aging are largely preventable through structured training. The synaptic and signaling changes that persist in all older adults represent the unavoidable half where drugs will need to work. The decisions made about structured training in midlife determine which molecular trajectory muscle follows in later decades. Half of muscle aging is optional. The other half isn't. Knowing which changes belong to each category is knowing where behavior ends and biology takes over.

Most aging theories focus on specific mechanisms—mitochondrial dysfunction, telomere attrition, chronic inflammation. But a new paper in npj Aging proposes that these aren't independent processes. They're downstream consequences of a single upstream imbalance. The autonomic nervous system has two opposing branches: the sympathetic nervous system (SNS), which drives the fight-or-flight response, and the parasympathetic nervous system (PNS), which activates rest-and-repair mechanisms. In a balanced state, these systems regulate each other. The SNS responds to stressors that disrupt homeostasis. The PNS restores homeostasis. Acute SNS activation followed by PNS recovery maintains physiological stability. But with aging, this balance breaks down. The SNS becomes hyperreactive. The PNS becomes underactive. Chronic SNS activation without PNS recovery drives the system into persistent divergence from homeostatic balance. This isn't just a biomarker change. It's a shift in the regulatory architecture that controls nearly every hallmark of aging. Chronic SNS activation increases catecholamine metabolism, which generates free radicals that damage mitochondrial DNA. mtDNA damage triggers Toll-like receptor 9 and STING inflammatory pathways. Catecholamines also elevate mitochondrial calcium levels, disrupting outer membrane permeability and deregulating apoptotic signaling. The result is mitochondrial dysfunction—not as an isolated aging mechanism, but as a consequence of sustained sympathetic overactivation. PNS activation does the opposite. It activates mitochondrial α7 nicotinic acetylcholine receptors, reducing calcium permeability and mtDNA release. It suppresses inflammatory TLR9 and STING signaling. It enhances PGC-1α activity, promoting mitochondrial biogenesis, fusion, fission, and mitophagy. PNS-mediated repair mechanisms restore mitochondrial function—but only when PNS signaling is sufficient to counterbalance SNS-driven damage. The same pattern applies to inflammation. Chronic catecholamine release causes receptor desensitization and dysregulation, which enhances NF-κB-driven inflammasome activity and creates the low-grade chronic inflammation known as inflammaging. PNS activation reverses this through cholinergic anti-inflammatory pathways. Acetylcholine binds to α7 nicotinic receptors on immune cells, inhibiting NF-κB and activating JAK2/STAT3 pathways that reduce pro-inflammatory cytokine transcription. Reduced vagal function—diminished PNS activity—causes immunosenescence in both innate and adaptive immunity, increasing loads of reactive macrophages and promoting age-related disease. The framework extends to nutrient sensing, epigenetic regulation, and proteostasis. Each hallmark of aging can be traced back to SNS:PNS imbalance operating through specific molecular pathways. This isn't a rejection of previous aging theories. It's a unifying model that positions autonomic nervous system deregulation as the upstream driver that produces the downstream mechanisms those theories describe. Raymond Pearl's Rate of Living theory proposed that metabolic rate inversely correlates with lifespan. The SNS:PNS deregulation model offers a mechanistic explanation—chronic SNS activation increases metabolic rate and energy expenditure without corresponding PNS-mediated recovery. The free radical theory of aging identifies oxidative damage as a central mechanism. The SNS:PNS model explains why free radical generation increases with age—persistent catecholamine metabolism and NADPH oxidase activation driven by SNS hyperactivity. Inflammaging has been recognized as a critical risk factor for age-related diseases. The model shows how SNS:PNS imbalance creates the conditions for chronic inflammation by disrupting cholinergic anti-inflammatory pathways. What makes this framework therapeutically relevant is that autonomic balance is modifiable. Vagal nerve stimulation, cholinergic agonists, and interventions that enhance PNS activity represent potential strategies to restore homeostatic balance. The decisions made in the fourth and fifth decades about behaviors that affect autonomic tone—chronic stress exposure, physical activity patterns, sleep quality—may determine whether SNS:PNS balance is maintained or whether the system shifts toward chronic sympathetic dominance. Aging may not be an inevitable accumulation of random damage. It may be the predictable consequence of a regulatory system that, over decades, loses its ability to return to baseline after stress. The question isn't whether mitochondrial dysfunction or chronic inflammation occur with aging. The question is whether those processes reflect irreversible cellular decline or sustained autonomic imbalance that can be corrected by restoring parasympathetic function.